- Weekly Olio
- Posts
- PopVax And The Case For Indian Biotech
PopVax And The Case For Indian Biotech
Dream, Pixxel, Most Valuable Startups, and Psychedelics Kingpin
Peeyush Jain & Mohit Garg
June 18, 2025
In partnership with
Salutations, Olio aficionados! 👋
Midweek greetings to all, as we unveil the 161st chapter of Weekly Olio—a delightful concoction of laughter, insight, and a sprinkle of mystery. Within these pages, you'll discover a handpicked selection of fascinating finds from the vast realms of the internet.
Keep your eyes peeled for this week’s Publisher’s Parmesan, arriving this Sunday!
A word from our Sponsors…
Find out why 1M+ professionals read Superhuman AI daily.
In 2 years you will be working for AI
Or an AI will be working for you
Here's how you can future-proof yourself:
Join the Superhuman AI newsletter – read by 1M+ people at top companies
Master AI tools, tutorials, and news in just 3 minutes a day
Become 10X more productive using AI
Join 1,000,000+ pros at companies like Google, Meta, and Amazon that are using AI to get ahead.
The Quote 💭
The Tweet 🐦
💡 From being scoffed at by investors to launching India's first hyperspectral satellites—this is how @awaisahmedna and @kshitijgokul are building India’s most ambitious space-tech startup.
In a pristine white laboratory, an engineer's hand trembles slightly while adjusting a
— Blume Ventures (@BlumeVentures)
7:20 AM • Jun 5, 2025
From being dismissed by investors to launching India's first hyperspectral satellites, Awais Ahmed and Kshitij Gokul have built India's leading space-tech startup, Pixxel. With three successful "Firefly" satellites in orbit and lucrative contracts, they've shown that breakthrough space technology can thrive in India. This is a story of precision, perseverance, and reaching for the stars.
The Infographic 💹
AI is king: Companies like Waymo (600x), OpenAI (70x), Anthropic (44x), and Perplexity (90x) are commanding sky-high multiples. Investors are betting big on the future of artificial intelligence — even when current revenue is modest.
Fact-based news without bias awaits. Make 1440 your choice today.
Overwhelmed by biased news? Cut through the clutter and get straight facts with your daily 1440 digest. From politics to sports, join millions who start their day informed.
The Short Read 📝
Interdimensional travel, intimate encounters with extraterrestrial beings, and profound communion with the divine—these are just a few of the extraordinary experiences that become possible with just a sprinkle of DMT. This powerful psychedelic compound, known for its ability to transport users to otherworldly realms, has captivated the imaginations of many seeking to explore the boundaries of consciousness. Read more…
The story follows a dark-web drug dealer who gained prominence by selling psychedelics like DMT online. Operating under a pseudonym, they built a large operation using cryptocurrency and encrypted communications to avoid law enforcement. Unlike traditional drug lords, they marketed psychedelics as tools for enlightenment, with a business model resembling a startup. Eventually, law enforcement caught up through cyber forensics and international cooperation, marking a victory against online drug trafficking. The story also examines the psychedelic renaissance, drug distribution ethics, and the intersection of criminality and counterculture.
The Long Read 📜
PopVax And The Case For Indian Biotech - by Tigerfeathers
Biotech is about to grow rapidly, and India could become a key player. We explore how a startup in Hyderabad is leading the way by combining computer methods with fast experiments. Read more…
India's biotech industry is starting to grow and break free from its limitations. Our future in innovation won't just be about software; it will also involve understanding and working with the building blocks of life, like amino acids, cell functions, and natural healing processes.
StartEngine’s $30M Surge — Own a Piece Before June 26
StartEngine is the investing platform providing exposure to pre-IPO companies like OpenAI, Perplexity, and Databricks.
After doubling their revenues YoY in 2024 ($23M to $48M), StartEngine’s now tripled first quarter revenue YoY to a record $30M, based on its unaudited Q1 2025 financials. Now you can join 45K+ shareholders across all offerings before this round closes next month.
Reg A+ via StartEngine Crowdfunding, Inc. No BD/intermediary involved. Investment is speculative, illiquid & high risk. See OC and Risks on page.
That’s all for this week. If you enjoyed this edition, we’d really appreciate if you shared it with a friend, family member or colleague.
We’ll be back in your inbox 2 PM IST next Wednesday. Till then, have a productive week!
Disclaimer: The views, thoughts, and opinions expressed in the text belong solely to the author, and not necessarily to the author's employer, organization, committee or other group or individual.
Reply